AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review
Open accessAbstract
DESCRIPTION: The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review is to provide clinicians with guidance on the use of noninvasive tests (NITs) in the evaluation and management of patients with nonalcoholic fatty liver disease (NAFLD). NAFLD affects nearly 30% of the global population and is a growing cause of end-stage liver disease and liver-related health care resource utilization. However, only a minority of all patients with NAFLD experience a liver-related outcome. It is therefore critically important for clinicians to assess prognosis and identify those with increased risk of disease progression and negative clinical outcomes at the time of initial assessment. It is equally important to assess disease trajectory over time, particularly in response to currently available therapeutic approaches. The reference standard for assessment of prognosis and disease monitoring is histologic examination of liver biopsy specimens. There are, however, many limitations of liver biopsies and their reading that have limited their use in routine practice. The utilization of NITs facilitates risk stratification of patients and longitudinal assessment of disease progression for patients with NAFLD. This clinical update provides best practice advice based on a review of the literature on the utilization of NITs in the management of NAFLD for clinicians. Accordingly, a combination of available evidence and consensus-based expert opinion, without formal rating of the strength and quality of the evidence, was used to develop these best practice advice statements. METHODS: This Expert Review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. These best practice advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these best practice advice statements do not carry formal ratings of the quality of evidence or strength of the presented considerations. Best Practice Advice Statements BEST PRACTICE ADVICE 1: NITs can be used for risk stratification in the diagnostic evaluation of patients with NAFLD. BEST PRACTICE ADVICE 2: A Fibrosis 4 Index score <1.3 is associated with strong negative predictive value for advanced hepatic fibrosis and may be useful for exclusion of advanced hepatic fibrosis in patients with NAFLD. BEST PRACTICE ADVICE 3: A combination of 2 or more NITs combining serum biomarkers and/or imaging-based biomarkers is preferred for staging and risk stratification of patients with NAFLD whose Fibrosis 4 Index score is >1.3. BEST PRACTICE ADVICE 4: Use of NITs in accordance with manufacturer's specifications (eg, not in patients with ascites or pacemakers) can minimize risk of discordant results and adverse events. BEST PRACTICE ADVICE 5: NITs should be interpreted with context and consideration of pertinent clinical data (eg, physical examination, biochemical, radiographic, and endoscopic) to optimize positive predictive value in the identification of patients with advanced fibrosis. BEST PRACTICE ADVICE 6: Liver biopsy should be considered for patients with NIT results that are indeterminate or discordant; conflict with other clinical, laboratory, or radiologic findings; or when alternative etiologies for liver disease are suspected. BEST PRACTICE ADVICE 7: Serial longitudinal monitoring using NITs for assessment of disease progression or regression may inform clinical management (ie, response to lifestyle modification or therapeutic intervention). BEST PRACTICE ADVICE 8: Patients with NAFLD and NITs results suggestive of advanced fibrosis (F3) or cirrhosis (F4) should be considered for surveillance of liver complications (eg, hepatocellular carcinoma screening and variceal screening per Baveno criteria). Patients with NAFLD and NITs suggestive of advanced hepatic fibrosis (F3) or (F4), should be monitored with serial liver stiffness measurement; vibration controlled transient elastography; or magnetic resonance elastography, given its correlation with clinically significant portal hypertension and clinical decompensation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MASLD-related consultations often center around risk stratification, diagnostic workup, and management of underlying metabolic conditions.
“These consultations often center around risk stratification, diagnostic workup, and management of underlying metabolic conditions.22”
From Large Language Model–Generated Electronic Consultations: A Blinded Comparative Study of OpenEvidence and Gastroenterologist Electronic Consultations (2026) · cites this paper as [22]
The evaluation algorithm (Conclusions; page not available) supports diagnostic workup and fibrosis risk stratification for patients with suspected NAFLD. The review discusses specialist referrals, but the passages do not establish what consultations often center on or say that they include management of underlying metabolic conditions. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · see citing works
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383 · see citing works
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works
Baveno VII – Renewing consensus in portal hypertension
de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J. G., Albillos, A., Baiges, A., Bajaj, J., Bañares, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.022 · Cited by 2,930 · see citing works
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works
Self-citationNon-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149 · see citing works
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106 · see citing works
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · see citing works
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A. D., Murray, K. F., Tetri, B., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,561 · see citing works
Self-citationNon-invasive evaluation of liver fibrosis using transient elastography
Castéra, L., Forns, X., & Alberti, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.008 · Cited by 1,433 · see citing works
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Sanyal, A. J., Van Natta, M. L., Clark, J., Neuschwander-Tetri, B. A., Diehl, A., Dasarathy, S., Loomba, R., Chalasani, N., Kowdley, K., Hameed, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029349 · Cited by 1,146 · see citing works
Self-citationCusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021 · see citing works
McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D., & Day, C. P. (2010) · Gut · doi:10.1136/gut.2010.216077 · Cited by 946 · see citing works
Xiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G. (2017) · Hepatology · doi:10.1002/hep.29302 · Cited by 895 · see citing works
Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A. H., Boursier, J., Chan, W., Yilmaz, Y. N., Czernichow, S., Zheng, M., Wong, V. W., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30383-8 · Cited by 823 · see citing works
Singal, A. G., Pillai, A., & Tiro, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001624 · Cited by 817 · see citing works
Guha, I. N., Parkes, J., Roderick, P. J., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2007) · Hepatology · doi:10.1002/hep.21984 · Cited by 744 · see citing works
Siddiqui, M. S., Vuppalanchi, R., Natta, M. L. V., Hallinan, E., Kowdley, K. V., Abdelmalek, M. F., Neuschwander‐Tetri, B. A., Loomba, R. S., Dasarathy, S., Brandman, D., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.043 · Cited by 618 · see citing works
Self-citationKanwal, F., Shubrook, J. H., Adams, L. A., Pfotenhauer, K., Wai-Sun Wong, V., Wright, E., Abdelmalek, M. F., Harrison, S. A., Loomba, R., Mantzoros, C. S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.049 · Cited by 618 · see citing works
Self-citationHarrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.027 · Cited by 497 · see citing works
Self-citationMózes, F. E., Lee, J. A., Selvaraj, E. A., Jayaswal, A. N. A., Trauner, M., Boursier, J., Fournier, C., Staufer, K., Stauber, R. E., Bugianesi, E., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324243 · Cited by 477 · see citing works
Srivastava, A., Gailer, R., Tanwar, S., Trembling, P. M., Parkes, J., Rodger, A. J., Suri, D., Thorburn, D., Sennett, K., Morgan, S., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.033 · Cited by 449 · see citing works
Hsu, C. L., Caussy, C., Imajo, K., Chen, J., Singh, S., Kaulback, K., Le, M., Hooker, J. C., Tu, X. M., Bettencourt, R., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.059 · Cited by 422 · see citing works
Association of histologic disease activity with progression of nonalcoholic fatty liver disease
Kleiner, D. E., Brunt, E. M., Wilson, L. A., Behling, C., Guy, C., Contos, M., Cummings, O., Yeh, M., Gill, R., Chalasani, N., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12565 · Cited by 372 · see citing works
Self-citationAnstee, Q. M., Lawitz, E. J., Alkhouri, N., Wong, V. W., Romero‐Gomez, M., Okanoue, T., Trauner, M., Kersey, K., Li, G., Han, L., et al. (2019) · Hepatology · doi:10.1002/hep.30842 · Cited by 277 · see citing works
Vuppalanchi, R., Siddiqui, M. S., Natta, M. L. V., Hallinan, E., Brandman, D., Kowdley, K. V., Neuschwander‐Tetri, B. A., Loomba, R. S., Dasarathy, S., Abdelmalek, M. F., et al. (2017) · Hepatology · doi:10.1002/hep.29489 · Cited by 262 · see citing works
Self-citationLiver fibrosis scores predict liver disease mortality in the United States population
Ünalp–Arida, A., & Ruhl, C. E. (2017) · Hepatology · doi:10.1002/hep.29113 · Cited by 261 · see citing works
Pons, M., Augustin, S., Scheiner, B., Guillaume, M., Rosselli, M., Rodrigues, S. G., Stefanescu, H., Ma, M. M., Mandorfer, M., Mergeay-Fabre, M., et al. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000994 · Cited by 260 · see citing works
Sun, W., Cui, H., Li, N., Wei, Y., Lai, S., Yang, Y., Yin, X., & Chen, D. (2016) · Hepatology Research · doi:10.1111/hepr.12647 · Cited by 236 · see citing works
Petta, S., Sebastiani, G., Viganò, M., Ampuero, J., Wai-Sun Wong, V., Boursier, J., Berzigotti, A., Bugianesi, E., Fracanzani, A. L., Cammà, C., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.045 · Cited by 197 · see citing works
Chen, J., Yin, M., Talwalkar, J. A., Oudry, J., Glaser, K. J., Smyrk, T. C., Miette, V., Sandrin, L., & Ehman, R. L. (2016) · Radiology · doi:10.1148/radiol.2016160685 · Cited by 175 · see citing works
Sanyal, A. J., Anstee, Q. M., Trauner, M., Lawitz, E. J., Abdelmalek, M. F., Ding, D., Han, L., Jia, C., Huss, R. S., Chung, C., et al. (2022) · Hepatology · doi:10.1002/hep.32204 · Cited by 171 · see citing works
Self-citationRinella, M. E., Dufour, J.-F., Anstee, Q. M., Goodman, Z., Younossi, Z., Harrison, S. A., Loomba, R., Sanyal, A. J., Bonacci, M., Trylesinski, A., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.029 · Cited by 164 · see citing works
Jung, J., Loomba, R., Imajo, K., Madamba, E. V., Gandhi, S., Bettencourt, R., Singh, S., Hernandez, C., Valasek, M. A., Behling, C. A., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322976 · Cited by 163 · see citing works
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Allen, A. M., Lazarus, J. V., & Younossi, Z. M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.026 · Cited by 156 · see citing works
Petta, S., Sebastiani, G., Bugianesi, E., Viganò, M., Wong, V. W.-S., Berzigotti, A., Fracanzani, A. L., Anstee, Q. M., Marra, F., Barbara, M., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.019 · Cited by 140 · see citing works
Imajo, K., Honda, Y., Kobayashi, T., Nagai, K., Ozaki, A., Iwaki, M., Kessoku, T., Ogawa, Y., Takahashi, H., Saigusa, Y., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.016 · Cited by 140 · see citing works
Repeatability of MR Elastography of Liver: A Meta-Analysis
Serai, S. D., Obuchowski, N. A., Venkatesh, S. K., Sirlin, C. B., Miller, F. H., Ashton, E. A., Cole, P. E., & Ehman, R. L. (2017) · Radiology · doi:10.1148/radiol.2017161398 · Cited by 136 · see citing works
Kim, B. K., Tamaki, N., Imajo, K., Yoneda, M., Sutter, N., Jung, J., Tuo, L., Tu, X. M., Bergstrom, J., Nguyen, K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.020 · Cited by 109 · see citing works
Nascimbeni, F., Lebray, P., Fedchuk, L., Oliveira, C. P., Alvares-da-Silva, M. R., Varault, A., Ingiliz, P., Ngo, Y., de Torres, M., Munteanu, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.037 · Cited by 82 · see citing works
Jayaswal, A. N. A., Levick, C., Selvaraj, E. A., Dennis, A., Booth, J., Collier, J. D., Cobbold, J., Tunnicliffe, E. M., Kelly, M., Barnes, E. J., et al. (2020) · Liver International · doi:10.1111/liv.14625 · Cited by 80 · see citing works
Vilar-Gomez, E., Lou, Z., Kong, N., Vuppalanchi, R., Imperiale, T. F., & Chalasani, N. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.017 · Cited by 75 · see citing works
Fagan, K. J., Pretorius, C. J., Horsfall, L. U., Irvine, K. M., Wilgen, U., Choi, K., Fletcher, L. M., Tate, J. R., Melino, M., Nusrat, S., et al. (2014) · Liver International · doi:10.1111/liv.12760 · Cited by 74 · see citing works
Patel, P. J., Hossain, F., Horsfall, L. U., Banh, X., Hayward, K. L., Williams, S., Johnson, T., Bernard, A., Brown, N. N., Lampe, G., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1208 · Cited by 74 · see citing works
Morling, J. R., Fallowfield, J. A., Guha, I. N., Nee, L. D., Glancy, S., Williamson, R. M., Robertson, C. M., Strachan, M. W. J., & Price, J. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.017 · Cited by 70 · see citing works
Gidener, T., Dierkhising, R. A., Mara, K. C., Therneau, T. M., Venkatesh, S. K., Ehman, R. L., Yin, M., & Allen, A. M. (2023) · Hepatology · doi:10.1002/hep.32594 · Cited by 62 · see citing works
Tamaki, N., Imajo, K., Sharpton, S. R., Jung, J., Kawamura, N., Yoneda, M., Valasek, M. A., Behling, C. A., Sirlin, C. B., Nakajima, A., et al. (2021) · Hepatology · doi:10.1002/hep.32145 · Cited by 60 · see citing works
Majumdar, A., Campos, S., Gurusamy, K. S., Pinzani, M., & Tsochatzis, E. A. (2019) · Hepatology · doi:10.1002/hep.30846 · Cited by 58 · see citing works
Gidener, T., Yin, M., Dierkhising, R., Allen, A. M., Ehman, R. L., & Venkatesh, S. K. (2021) · Hepatology · doi:10.1002/hep.32151 · Cited by 57 · see citing works
Kjærgaard, M., Thiele, M. S., Jansen, C., Madsen, B. S., Görtzen, J., Strassburg, C. P., Trebicka, J., & Krag, A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173992 · Cited by 53 · see citing works
Chow, J. C., Wong, G. L., Chan, A. W., Shu, S. S., Chan, C. K., Leung, J. K., Choi, P. C., Chim, A. M., Chan, H. L., & Wong, V. W. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14311 · Cited by 46 · see citing works
Miele, L., Michele, T. D., Marrone, G., Isgrò, M. A., Basile, U., Cefalo, C., Biolato, M., Vecchio, F. M., Rapaccini, G. L., Gasbarrini, A., et al. (2017) · The International Journal of Biological Markers · doi:10.5301/ijbm.5000292 · Cited by 38 · see citing works
Kamarajah, S. K., Chan, W., Mustapha, N. R. N., & Mahadeva, S. (2018) · Hepatology International · doi:10.1007/s12072-018-9843-4 · Cited by 36 · see citing works
van Kleef, L. A., Sonneveld, M. J., de Man, R. A., & de Knegt, R. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.017 · Cited by 35 · see citing works
Mosca, A., Volpe, L. D., Alisi, A., Veraldi, S., Francalanci, P., & Maggiore, G. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.885576 · Cited by 21 · see citing works
Liver stiffness measurement in non‐alcoholic fatty liver disease: Two is better than one
Chuah, K. H., Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14978 · Cited by 20 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960 · see citing works
Le, P., Tatar, M., Dasarathy, S., Alkhouri, N., Herman, W. H., Taksler, G. B., Deshpande, A., Ye, W., Adekunle, O. A., McCullough, A. J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54707 · Cited by 261 · see citing works
Chew, N., Mehta, A., Goh, R. S. J., Zhang, A. A. Y., Chen, Y., Chong, B., Chew, H. S. J., Shabbir, A., Brown, A. C., Dimitriadis, G. K., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.070535 · Cited by 185 · see citing works
Self-citationKokkorakis, M., Boutari, C., Hill, M. A., Kotsis, V., Loomba, R., Sanyal, A. J., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155835 · Cited by 155 · see citing works
Self-citationFerraioli, G., Barr, R. G., Berzigotti, A., Sporea, I., Wong, V. W., Reiberger, T., Karlas, T., Thiele, M. S., Cardoso, A. C., Ayonrinde, O. T., et al. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.03.013 · Cited by 160 · see citing works
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Kalligeros, M., Henry, L. L., & Younossi, Z. M. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156004 · Cited by 113 · see citing works
Byrne, C. D., Armandi, A., Pellegrinelli, V., Vidal‐Puig, A., & Bugianesi, E. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01045-z · Cited by 109 · see citing works
Zhang, X., Zheng, M., Liu, D., Lin, Y., Song, S. J., Chu, E. S., Liu, D., Singh, S., Berman, M., Lau, H. C.-H., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.008 · Cited by 67 · see citing works
Díaz, L. A., Arab, J. P., Idalsoaga, F. J., Perelli, J., Vega, J. A., Dirchwolf, M., Carreño, J., Samith, B., Valério, C. M., Moreira, R. O., et al. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101903 · Cited by 66 · see citing works
The growing range of complications of diabetes mellitus
Hamblin, P. S., Russell, A. W., Talic, S., & Zoungas, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.006 · Cited by 51 · see citing works
Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
Dawod, S. M., & Brown, K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1499013 · Cited by 48 · see citing works
Surveillance of the liver in type 2 diabetes: important but unfeasible?
Qadri, S. U., & Yki‐Järvinen, H. (2024) · Diabetologia · doi:10.1007/s00125-024-06087-7 · Cited by 44 · see citing works
Zhou, X., Li, Y., Kim, S. U., Yip, T. C., Petta, S., Nakajima, A., Tsochatzis, E. A., Shi, J., Chan, W., Boursier, J., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.07.011 · Cited by 36 · see citing works
Self-citationHudson, D., Afzaal, T., Bualbanat, H., AlRamdan, R., Howarth, N., Parthasarathy, P., Al-Darwish, A., Stephenson, E., Almahanna, Y., Hussain, M., et al. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241276334 · Cited by 39 · see citing works
Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD
Long, X., Wang, H., Lu, Y., Gao, X., Xiao, Y., Zhang, M., Guo, J., Yang, H. J., Zhang, R., Li, Q., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.017 · Cited by 37 · see citing works
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Lonardo, A., Ballestri, S., Mantovani, A., Targher, G., & Bril, F. (2024) · Metabolites · doi:10.3390/metabo14010040 · Cited by 34 · see citing works
Lindfors, A., Strandberg, R., & Hagström, H. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00313-3 · Cited by 33 · see citing works
MetALD : New Perspectives on an Old Overlooked Disease
Ayares, G., Díaz, L. A., Idalsoaga, F. J., Alkhouri, N., Noureddin, M., Bataller, R. A., Loomba, R. S., Arab, J. P., & Arrese, M. A. (2025) · Liver International · doi:10.1111/liv.70017 · Cited by 34 · see citing works
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
Chew, N., Mehta, A., Goh, R. J. L., Koh, J., Chen, Y., Chong, B., Chan, M. Y., Khan, M. S., Muthiah, M. D., Butler, J., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01220-4 · Cited by 35 · see citing works
Self-citationWang, Y., Song, S. J., Jiang, Y., Lai, J. C., Wong, G. L., Wong, V. W., & Yip, T. C. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0246 · Cited by 32 · see citing works
MASLD: What We Have Learned and Where We Need to Go—A Call to Action
Shabanan, S. H., Martins, V. F., Wolfson, T. J., Weeks, J. T., Ceriani, L., Behling, C. A., Chernyak, V., Kaffas, A. E., Borhani, A. A., Han, A., et al. (2024) · Radiographics · doi:10.1148/rg.240048 · Cited by 31 · see citing works
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Díaz, L. A., Thiele, M. S., Louvet, A., Lee, B. P., Ajmera, V. H., Tavaglione, F., Hsu, C. L., Huang, D. Q., Pose, E., Bataller, R. A., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01120-5 · Cited by 31 · see citing works
Self-citationLai, J. C., Yang, B., Lee, H. W., Lin, H., Tsochatzis, E. A., Petta, S., Bugianesi, E., Yoneda, M., Zheng, M., Hagström, H., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-334981 · Cited by 32 · see citing works
Self-citationSung, S., Al‐Karaghouli, M., Tam, M., Wong, Y. J., Jayakumar, S., Davyduke, T., Ma, M. M., & Abraldeṣ, J. G. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000609 · Cited by 30 · see citing works
Suresh, M. G., Mohamed, S., Geetha, H. S., Prabhu, S., Trivedi, N., Ng, Z. C., Mehta, P. D., Brar, A. S., Sohal, A., Goyal, M. K., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.113149 · Cited by 30 · see citing works
Zhang, G. Y., & Brandman, D. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.6431 · Cited by 27 · see citing works
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Lonardo, A., Ballestri, S., Baffy, G., & Weiskirchen, R. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.42 · Cited by 29 · see citing works
Misra, A., Kumar, A., Kuchay, M. S., Ghosh, A., Gulati, S., Choudhary, N. S., Dutta, D., Sharma, P., Vikram, N. K., Rastogi, A., et al. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103209 · Cited by 27 · see citing works
Díaz, L. A., Ajmera, V. H., Arab, J. P., Huang, D. Q., Hsu, C. L., Lee, B. P., Louvet, A., Thiele, M. S., Tavaglione, F., Tincopa, M. A., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.02.017 · Cited by 28 · see citing works
Arai, T., Takahashi, K., Seko, Y., Toyoda, H., Hayashi, H., Yamaguchi, K., Iwaki, M., Yoneda, M., Shima, T., Fujii, H., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.022 · Cited by 26 · see citing works
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD
Frączek, J., Sowa, A., Agopsowicz, P., Migacz, M., Dylińska-Kala, K., & Holecki, M. T. (2025) · Medicina · doi:10.3390/medicina61040736 · Cited by 26 · see citing works
Fan, W., Bradford, T. M., & Török, N. J. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15184 · Cited by 25 · see citing works
Guney-Coskun, M., & Başaranoğlu, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i43.4682 · Cited by 24 · see citing works
Hansen, C. D., Hansen, J. K., Israelsen, M. E., Andersen, P., Pikkupeura, L. M., Lindvig, K. P., Stinson, S. E., Schnefeld, H. L., Tellerup, J., Fogt, M., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.06.020 · Cited by 23 · see citing works
Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review
Cumpian, N. A., Gutierrez, J. A., Wu, W., & Saab, S. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.4769 · Cited by 22 · see citing works
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Alisi, A., Mccaughan, G., & Grønbæk, H. (2024) · Hepatology International · doi:10.1007/s12072-024-10674-6 · Cited by 21 · see citing works
Pecani, M., Andreozzi, P., Cangemi, R., Corica, B., Miglionico, M., Romiti, G. F., Stefanini, L., Raparelli, V., & Basili, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082750 · Cited by 22 · see citing works
Cusi, K. J., Budd, J., Johnson, E. L., & Shubrook, J. H. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0014 · Cited by 20 · see citing works
Castéra, L., Alazawi, W., Bugianesi, E., Caussy, C., Federici, M., Romero‐Gómez, M., Schattenberg, J. M., Basuroy, R., Prasad, P., Estulin, D., et al. (2025) · Liver International · doi:10.1111/liv.16224 · Cited by 19 · see citing works
Bharaj, I. S., Brar, A. S., Kahlon, J., Singh, A., Hotwani, P., Kumar, V., Sohal, A., & Batta, A. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i6.106147 · Cited by 19 · see citing works
Díaz, L. A., Tavaglione, F., Mittal, N., Bettencourt, R., Amangurbanova, M., Johnson, A., Aguado, D. M., Tincopa, M. A., Loomba, R. K., Khan-Riches, A., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000718 · Cited by 19 · see citing works
Liu, S., Chen, X., Jiang, X., Yin, X., Fekadu, G., Liu, C., He, Y., Chen, H., Ni, W., Wang, R., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.003 · Cited by 18 · see citing works
Chouik, Y., Aubin, A., Maynard, M., Segrestin, B., Milot, L. M., Hervieu, V., Zoulim, F., Disse, E., Levrero, M., & Caussy, C. (2024) · Obesity · doi:10.1002/oby.24033 · Cited by 18 · see citing works
Xiu, M., Li, B., He, L., Shi, Y., Zhang, Y., Zhou, S., Liu, Y., Wang, N., & He, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s499284 · Cited by 18 · see citing works
Liu, Y., Qin, X., Chen, T., Chen, M., Wu, L., & He, B. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1344924 · Cited by 17 · see citing works
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Chui, Z. S. W., Xue, Y.-Q., & Xu, A.-M. (2024) · Medical Review · doi:10.1515/mr-2024-0007 · Cited by 18 · see citing works
Yeh, M., Huang, J., Dai, C., Huang, C., Yu, M., & Chuang, W. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2388790 · Cited by 16 · see citing works
Noninvasive assessment of liver fibrosis and portal hypertension
Duarte‐Rojo, A., Patel, K., & Rockey, D. C. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001019 · Cited by 16 · see citing works
Huang, J., Chang, T., Yeh, M., Shen, F., Tai, C., Chen, J., Huang, Y., Hsu, C., Cheng, P., Lin, C., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000571 · Cited by 15 · see citing works
Detecting at-risk steatotic liver disease and liver fibrosis in the community
Adams, L. A., Thiele, M. S., & Tsochatzis, E. A. (2025) · Hepatology · doi:10.1097/hep.0000000000001400 · Cited by 14 · see citing works
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD
Thakral, N., Desalegn, H., Díaz, L. A., Cabrera, D., Loomba, R. S., Arrese, M. A., & Arab, J. P. (2024) · Seminars in Liver Disease · doi:10.1055/a-2364-2928 · Cited by 14 · see citing works
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
Song, B. G., Kim, A., Goh, M. J., Kang, W., Gwak, G., Paik, Y., Choi, M. S., Lee, J. H., & Sinn, D. H. (2024) · Liver Cancer · doi:10.1159/000538301 · Cited by 13 · see citing works
Allen, A. M., Lazarus, J. V., Alkhouri, N., Noureddin, M., Wong, V. W., Tsochatzis, E. A., de Avila, L., Racila, A., Nader, F., Mark, H. E., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000678 · Cited by 12 · see citing works
Aldana, S. I., Midya, V., Betanzos‐Robledo, L., Yao, M., Alcala, C. S., Andra, S. S., Arora, M., Calafat, A. M., Chu, J., Deierlein, A. L., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.11.050 · Cited by 12 · see citing works
Kokkorakis, M., Folkertsma, P., Forte, J. C., Wolffenbuttel, B. H. R., van Dam, S., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156047 · Cited by 11 · see citing works
Golgi protein 73 in liver fibrosis
Szternel, Ł., Sobucki, B., Wieprzycka, L., Krintus, M., & Panteghini, M. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119999 · Cited by 11 · see citing works
Han, Y., Tang, J., Wu, N., Li, Z., Ren, H. G., Hu, P., & Chen, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156096 · Cited by 11 · see citing works
Lean MASLD and Cardiovascular Disease: A Review
Lebovics, N., Heering, G., Frishman, W. H., & Lebovics, E. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000893 · Cited by 11 · see citing works
Concepción‐Zavaleta, M. J., Fuentes‐Mendoza, J. M., Yovera, J. G. G., Ruvalcaba-Barbosa, G. Y., Cura-Rodríguez, L. D., González-Rodríguez, J. S., Urteaga, L. A. C., Pérez-Reyes, A. I., Aldave, J. E. Q., & Paz‐Ibarra, J. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i37.111435 · Cited by 10 · see citing works
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD
Hegmar, H., Wiggers, T., Nasr, P., Vessby, J., Kechagias, S., Nyhlin, N., Marschall, H., Borssén, Å. D., Strandberg, R., Karsdal, M. A., et al. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13813 · Cited by 10 · see citing works
Song, B. G., Goh, M. J., Kang, W., Gwak, G., Paik, Y., Choi, M. S., Lee, J. H., & Sinn, D. H. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18402 · Cited by 10 · see citing works
Langmann, F., Ibsen, D. B., Johnston, L., Perez‐Cornago, A., & Dahm, C. C. (2024) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70004 · Cited by 9 · see citing works
Muñoz‐Espinosa, L. E., Torre, A., Cisneros, L., Montalvo, I., Malé, R., Mejía, S., Aguilar, J. R., Lizardi, J., Zuñiga‐Noriega, J., Eugenia Icaza, M., et al. (2025) · Liver International · doi:10.1111/liv.70131 · Cited by 10 · see citing works
Clinical Assessment of People With Obesity: Focus on Adiposity-Related Multimorbidity
Bianchettin, R. G., Gawey, B. J., Acosta, A. J., Borlaug, B. A., Caples, S. M., Collazo–Clavell, M. L., Clark, M. M., Lara-Breitinger, K. M., Lerman, A., Lerman, L. O., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.02.021 · Cited by 12 · see citing works
Kim, A., Kang, D., Choi, S. C., Cho, J., Sinn, D. H., & Gwak, G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301126 · Cited by 9 · see citing works
Coşkun, M., Şendur, H. N., Babayeva, A., Cerit, M. N., Cerit, E. T., Yalçın, M. M., Altınova, A. E., Aktürk, M., Karakoç, M. A., & Törüner, F. B. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02384-5 · Cited by 9 · see citing works
Panteghini, M., & Wielgosz, R. I. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0401 · Cited by 9 · see citing works
The relationship between hepatic steatosis index and hypertension: NHANES 2011–2018
Zhang, W., Gao, B., Wang, Y., Cao, Y., & Wang, J. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04744-2 · Cited by 9 · see citing works
Aitharaju, V., Ragheb, J. G., Firkins, S. A., Patel, R., & Simons-Linares, C. R. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.09.012 · Cited by 8 · see citing works
Velji-Ibrahim, J., Woodard, J. S., Alden, J., & Abrams, G. A. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002132 · Cited by 8 · see citing works
Trifylli, E.-M., Angelakis, A., Kriebardis, A. G., Papadopoulos, N., Fortis, S. P., Pantazatou, V., Koskinas, J. S., Kranidioti, H., Koustas, E., Sarantis, P., et al. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i22.106937 · Cited by 8 · see citing works
Nakamura, A., Yoshimura, T., Ichikawa, T., & Okuyama, K. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101507 · Cited by 7 · see citing works
Volčanšek, Š., Janež, A., Rizzo, M., & Muzurović, E. M. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108875 · Cited by 7 · see citing works
Woodard, J. S., Velji-Ibrahim, J., & Abrams, G. A. (2024) · Diseases · doi:10.3390/diseases12110288 · Cited by 7 · see citing works
Talha, M., Ali, M. H., Nadeem, Z. A., Akram, U., Saravanan, P. B., & Khalid, M. H. A. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002892 · Cited by 7 · see citing works
Schonfeld, E. A., Kierans, A. S., Fox, R. K., & Brandman, D. (2025) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2024.12.014 · Cited by 7 · see citing works
Hernandez, R., García-Rodríguez, N., Arriaga, M. A., Pérez, R., Bala, A. A., Leandro, A., Diego, V. P., Almeida, M., Parsons, J., Manusov, E., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1513598 · Cited by 7 · see citing works
Thallapureddy, K., Twitchell, D., Ott, K., Pedicone, L. D., Owo, C., Kumar, N., Gelfond, J., Shankar, N., Goros, M. W., Kwok, D., et al. (2025) · Medicine · doi:10.1097/md.0000000000042016 · Cited by 7 · see citing works
Xiao, L., Zeng, L., Wang, J., Hong, C., Zhang, Z., Wu, C., Cui, H., Li, Y., Li, R., Liang, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202410527 · Cited by 7 · see citing works
Abaalkhail, F., Sanai, F. M., Alswat, K., Alzanbagi, A., Aljedai, A., Alshehri, A., Alfadda, A., Alghamdi, H., Almadi, M. A., Aleissa, M., et al. (2025) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_199_25 · Cited by 9 · see citing works
Hernández-Almonacid, P. G., & Marín-Quintero, X. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i2.111737 · Cited by 8 · see citing works
Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
Mak, L. (2024) · Journal of Liver Cancer · doi:10.17998/jlc.2024.08.03 · Cited by 7 · see citing works
Deb, R., Goswami, S., Sengupta, N., Baidya, A., Khare, V. R., Datta, J., Das, M., & Ray, D. (2025) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_457_24 · Cited by 6 · see citing works
Sukocheva, O. A., Ow, T., Harding, D., Mire, M. L., & Tse, E. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106675 · Cited by 6 · see citing works
Djeagou, A., Gunukula, K., Sermani, A., & Vaspari, S. K. (2025) · Cureus · doi:10.7759/cureus.95288 · Cited by 6 · see citing works
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease
De, A., Chalasani, N., & Duseja, A. K. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2025.09.003 · Cited by 6 · see citing works
Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics
Feng, Y., Zhang, X., Wang, X., & Chen, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00490-9 · Cited by 7 · see citing works
Ananchuensook, P., Moonlisarn, K., Boonkaew, B., Bunchorntavakul, C., & Tangkijvanich, P. (2025) · Biomedicines · doi:10.3390/biomedicines13020415 · Cited by 5 · see citing works
Chang, K.-C., Lin, T., Wang, T., Chuang, S.-L., Lee, C.-C., Wu, C., Lin, L., Huang, K., & Lin, L. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3761 · Cited by 5 · see citing works
Liu, C., Li, C., Fu, J., Bai, L., Wang, M., Song, P., & Zheng, M. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04195-1 · Cited by 5 · see citing works
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
Ribeiro, T. C. R., Soares, V. D. P. B., Fabri, J. C., & Ramos, L. E. D. A. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i1.111534 · Cited by 5 · see citing works
Ghodrati, F., Zhang, A. B., & Mahmud, N. (2026) · Gastroenterology report · doi:10.1093/gastro/goag006 · Cited by 5 · see citing works
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases
Annapragada, A. V., Foda, Z. H., Orjuela, H., Norton, C., Koul, S., Niknafs, N., Short, S. B., Boyapati, K., Bartolomucci, A. L., Mathios, D., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adw2603 · Cited by 5 · see citing works
Gee, M. F. W., Fonstad, R. K., Vol, E. B. D., Brown, C., Feld, J. J., Patel, K., & Sanyal, A. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000931 · Cited by 5 · see citing works
Self-citationGál, A. R., Szokodi, I., Vizvári, Z., Győrfi, N., Vereczkei, A. G., Petykó, Z., Karádi, Z., & Tóth, A. (2026) · Antioxidants · doi:10.3390/antiox15060710 · Cited by 6 · see citing works
Younossi, Z. M., Estep, J. M., Felix, S. C., Lam, B. P., Younossi, Z., Racila, A., & Stepanova, M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111960 · Cited by 5 · see citing works
Hoang, T., Lee, J., Kim, B. H., Cho, Y., & Kim, J. (2025) · Cancer Research and Treatment · doi:10.4143/crt.2024.876 · Cited by 5 · see citing works
Quantitative Mapping of Fibrotic Tissue Mechanics via Brillouin Spectroscopy
Cheburkanov, V. D., Jung, S., Berezin, M. Y., & Yakovlev, V. V. (2025) · Journal of Biophotonics · doi:10.1002/jbio.202500489 · Cited by 4 · see citing works
Ebiai, R., McNair, J., Shuaibi, S. N., Memon, A. I., Desai, A., Fort, L. B., Seoane, L., Girgrah, N., & Therapondos, G. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100857 · Cited by 5 · see citing works
Krintus, M., & Panteghini, M. (2025) · Clinical Chemistry · doi:10.1093/clinchem/hvaf193 · Cited by 4 · see citing works
- Authors
- Wattacheril, J. J., Abdelmalek, M. F., Lim, J. K., & Sanyal, A. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Wattacheril, Julia J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 165
- Issue
- 4
- Pages
- 1080-1088
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4385567515
- Cited by
- 236
- References
- 56
- Citations by year
- 2026: 80 · 2025: 86 · 2024: 68 · 2023: 2
- FWCI
- 47.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Allergan
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- non-alcoholic fatty liver disease, non-invasive biomarkers, non-invasive tests, liver fibrosis, NAFLD fibrosis score, liver biopsy limitations, risk stratification, disease progression monitoring, liver disease staging, serum biomarkers, NAFLD risk prediction, NAFLD management
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Biomarkers, Disease Progression, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
